Long-term safety assessment of JNJ-81201887 for eye condition related to aging

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the long-term safety and tolerability of JNJ-81201887, an investigational treatment administered via intravitreal injection, in participants who previously received this treatment or a sham in earlier clinical studies. The study aims to gather data on the effects of the treatment over an extended period. Participants will be monitored for any adverse effects and overall health outcomes related to geographic atrophy secondary to age-related macular degeneration.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participants who were enrolled and received treatment with JNJ-81201887 or sham in a parent clinical study (81201887MDG2001, 81201887MDG1003)
* Females (women of childbearing potential), male participants, and partners of male participants will not be required to use contraception in this LTE study
* Must sign an informed consent form (ICF) indicating that participant understands the purpose of, and procedures required for, the study and is willing to participate in the study. The ICF may be signed by an impartial witness and/or legally designated representative depending on national/local regulations

Exclusion Criteria:

* There are no exclusion criteria for this LTE study

Where it's running

• Retina Associates Southwest PC
  Tucson, Arizona, United States Recruiting
• Retina Consultants of Orange County
  Fullerton, California, United States Recruiting
• Shiley Eye Institute Jacobs Retina Center
  La Jolla, California, United States Recruiting
• California Retina Consultants
  Oxnard, California, United States Recruiting
• California Eye Medical Specialists
  Pasadena, California, United States Recruiting
• Retina Consultants San Diego
  Poway, California, United States Recruiting

+54 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Study coordinator: Study Contact
• Email: Participate-In-This-Study1@its.jnj.com
• Phone: 844-434-4210

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Assessing a vision test for patients with macular degeneration and Stargardt disease

  This study is testing a new vision test to see how well it works for people with macular degeneration and Stargardt disease compared to standard vision tests.

  Recruiting Nanoscope Therapeutics Inc. · Dallas, Texas · NCT06805474

• Evaluating a stem cell treatment for geographic atrophy from dry age-related macular degeneration.

  This study is testing a new stem cell treatment for people with geographic atrophy from dry age-related macular degeneration to see if it can help improve their vision.

  Recruiting at 3 sites Phase 1/2 Eyestem Research Pvt. Ltd. · Jālna, Maharashtra and 2 other locations · NCT06394232

• Noninvasive imaging biomarkers to see if ophthalmic artery narrowing relates to geographic atrophy in age-related macular degeneration

  This study tests whether narrowed ophthalmic artery vessels are linked to the development or worsening of geographic atrophy in people with dry age-related macular degeneration.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07798323

• See if STL303 helps adults with geographic atrophy from AMD

  This study tests STL303 versus placebo in people 60 and older who have geographic atrophy due to age-related macular degeneration to see if it is safe and can help their vision.

  Recruiting at 3 sites Phase 2 Sitala Bio LTD · Bakersfield, California and 55 other locations · NCT07606365

• C.001 for retinal degeneration: a first-in-human dose-escalation safety test

  A first-in-human study will test the safety and tolerability of a single subretinal injection of C.001 in adults with retinal diseases involving retinal pigment epithelium degeneration.

  Recruiting at 2 sites Phase 1 Cellio Therapeutics Inc · Beverly Hills, California and 2 other locations · NCT07594236

• Multimodal-feedback vision rehabilitation for people with central vision loss

  This trial will test whether five weekly sessions of binocular multimodal feedback training can improve eye movement control in people with bilateral central vision loss from macular degeneration.

  Recruiting New England College of Optometry · Boston, Massachusetts · NCT07577219

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.